2010-02-08 10:04:20 -

APCER Pharma : announced that LPC Pharma Group is outsourcing its pharmacovigilance/drug safety : operations to APCER.

APCER is a leading global provider of comprehensive drug safety, regulatory services and risk management programs for pharmaceutical, biotechnology, medical device and consumer products companies.

LPC, based in Luton, specialises in the supply of branded and generic medicines across the UK. It owns the intellectual property for over 150 licences enabling supply of own label and several brands such as Uvistat sun cream, Dalivit Multivitamin Drops and Hill’s Balsam for Chesty and Dry Cough.

LPC Director Satnam Butter said, “APCER uses best in class, validated processes and technology. Their staff have excellent training and qualifications. Outsourcing our pharmacovigilance operations to the

experts at APCER allows LPC to focus our resources on our areas of expertise.”


Michael Reynolds, APCER’s Head of Sales and Marketing for Europe, Asia and Africa, said, “We’re delighted to be working with LPC. Maintaining the system is one of the most expensive, time-consuming burdens facing a pharmaceutical company. APCER is 100% committed to our customers’ successes. We maintain continuous contact through visits and regular updates, which enables smooth and efficient implementations. Our team becomes an extension of every client’s operation.”

Pharmaceutical companies must invest more resources and budget to manage their compliance with pharmacovigilance regulatory requirements within ICH regions. APCER’s pharmacovigilance/drug safety experts provide a complete range of services based on a fully electronic platform which is compliant with ICH–E2B (EU) and 21 CFR part 11 (US-FDA) regulatory requirements.


About APCER Pharma

APCER Pharma provides comprehensive drug safety, regulatory services and risk management programs to pharmaceutical, biotechnology, medical device, and consumer products companies. APCER provides customers with hosted safety data systems; service to receive, process, code and report (including electronic reporting) Adverse and Serious Adverse Events on behalf of its clients; and, other strategic Risk Management and Regulatory services. APCER’s scalable, rapid deployment processes ensure compliance, comprehensive understanding of a customer’s requirements and implementation of solutions that address current and future needs. For more information, visit www.apcerpharma.com : , call [+44] [0] 208 326 3220, or email info@apcpharma.co.uk : mailto:info@apcpharma.co.uk .



APCER PharmaBrenda Nashawaty, +1-617-688-3253 brenda.nashawaty@apcerpharma.com : mailto:brenda.nashawaty@apcerpharma.com